Form 4: Longeveron Chief Medical Officer Sells Shares to Cover Tax Obligations

Longeveron's Chief Medical Officer, Nataliya Agafonova, sold 6,120 shares of Class A Common Stock to cover tax obligations related to a restricted stock unit vesting.

Summary

• Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., sold 6,120 shares of Class A Common Stock on January 2, 2025.
• The sale was executed at a price of $1.79 per share.
• This transaction was to satisfy tax obligations related to the vesting of a restricted stock unit award.
• Following the transaction, Ms. Agafonova beneficially owns 151,694 shares, which includes restricted stock units subject to future vesting.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to equity compensation. It is common for executives to sell shares after vesting events.

Comparison to Industry Standards

• Similar transactions are common across the biotech industry, where stock-based compensation is a significant part of executive pay.
• Many executives at comparable companies such as BioMarin Pharmaceutical and Vertex Pharmaceuticals regularly sell shares to cover tax liabilities after vesting of stock options or restricted stock units.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Longeveron, insider trading, stock sale, Nataliya Agafonova, restricted stock units, tax obligations, LGVN, Chief Medical Officer